Quick Answer
Drugs Made In America Acquisition Corp. reported Common Stock Shares Outstanding of 9.86 million shares for the year ending 2024.
- This data is from Drugs Made In America Acquisition Corp.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2024 to 2024 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2024: 9.86 million shares | Q1 2025: 10.52 million shares | Q2 2025: 10.52 million shares | Q3 2025: 10.52 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: